BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11142575)

  • 1. Treatment failures and secondary resistance to antibiotics. A growing concern in Helicobacter pylori therapy.
    de Boer WA; Borody TJ
    Dig Liver Dis; 2000 Nov; 32(8):673-5. PubMed ID: 11142575
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.
    Pilotto A; Franceschi M; Rassu M; Leandro G; Bozzola L; Furlan F; Di Mario F
    Dig Liver Dis; 2000 Nov; 32(8):667-72. PubMed ID: 11142574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPI-based triple therapy in the eradication of H. pylori infection.
    Savarino V; Neri M; Vigneri S
    Gastroenterology; 1999 Sep; 117(3):746-7. PubMed ID: 10490365
    [No Abstract]   [Full Text] [Related]  

  • 4. Sequential therapy for Helicobacter pylori: time to consider making the switch?
    Vakil N; Vaira D
    JAMA; 2008 Sep; 300(11):1346-7. PubMed ID: 18799448
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic strategies in Helicobacter pylori infection].
    Calvet X; Gené E; Sanfeliu I
    Med Clin (Barc); 2001 Feb; 116(6):239. PubMed ID: 11333728
    [No Abstract]   [Full Text] [Related]  

  • 6. Lactobacillus acidophilus administration added to omeprazole/amoxycillin-based double therapy in Helicobacter pylori eradication.
    De Francesco V; Stoppino V; Sgarro C; Faleo D
    Dig Liver Dis; 2000 Nov; 32(8):746-7. PubMed ID: 11142590
    [No Abstract]   [Full Text] [Related]  

  • 7. Clarithromycin resistance in Helicobacter pylori: implications for therapy.
    Fujioka T
    J Gastroenterol; 2000; 35(1):69-70. PubMed ID: 10632546
    [No Abstract]   [Full Text] [Related]  

  • 8. [Should Helicobacter pylori be eradicated in patients with functional dyspepsia?].
    Elizalde I; Borda F
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 2():43-6. PubMed ID: 11968334
    [No Abstract]   [Full Text] [Related]  

  • 9. Proton pump inhibitor therapy and Helicobacter pylori infection: a complicated relationship.
    McColl K
    Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):185-6. PubMed ID: 16930290
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacologic aspects of eradication therapy for Helicobacter pylori Infection.
    Furuta T; Graham DY
    Gastroenterol Clin North Am; 2010 Sep; 39(3):465-80. PubMed ID: 20951912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori: novel therapies.
    Drouin E
    Can J Gastroenterol; 1999 Sep; 13(7):581-3. PubMed ID: 10519955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori.
    Seifrit B
    AORN J; 1997 Mar; 65(3):614-6, 619-20. PubMed ID: 9061156
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibiotic treatment of Helicobacter pylori infection.
    Unge P
    Curr Top Microbiol Immunol; 1999; 241():261-300. PubMed ID: 10087665
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapy and diagnostic tests used for Helicobacter pylori infection in the Scandinavian countries in 1998.
    Olafsson S; Berstad A
    Scand J Gastroenterol; 1999 Sep; 34(9):849-55. PubMed ID: 10522601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clarithromycin resistance in Helicobacter pylori infection: does it matter?
    Fock KM
    J Gastroenterol Hepatol; 2000 Oct; 15(10):1089-92. PubMed ID: 11106085
    [No Abstract]   [Full Text] [Related]  

  • 16. Institutional difference of antibiotic resistance of Helicobacter pylori strains in Korea.
    Kim N; Kim JM; Kim CH; Park YS; Lee DH; Kim JS; Jung HC; Song IS
    J Clin Gastroenterol; 2006 Sep; 40(8):683-7. PubMed ID: 16940878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on the Use of Vonoprazan: A Competitive Acid Blocker.
    Graham DY; Dore MP
    Gastroenterology; 2018 Feb; 154(3):462-466. PubMed ID: 29337157
    [No Abstract]   [Full Text] [Related]  

  • 18. Drugs for Helicobacter pylori infection.
    Med Lett Drugs Ther; 2017 Jul; 59(1525):113-117. PubMed ID: 28699931
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention of bleeding recurrence in peptic ulcer by Helicobacter pylori eradication].
    Gisbert JP
    Gastroenterol Hepatol; 2005 Nov; 28(9):567-75. PubMed ID: 16277966
    [No Abstract]   [Full Text] [Related]  

  • 20. Helicobacter pylori infection and antibiotic resistance: a WHO high priority?
    Dang BN; Graham DY
    Nat Rev Gastroenterol Hepatol; 2017 Jul; 14(7):383-384. PubMed ID: 28465548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.